Regulatory Review Modernization Development (KASA & OGD Label Tool, Struct Rev
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract supports the continued development and maintenance of two critical systems used by the Food and Drug Administration’s Center for Drug Evaluation and Research: the Knowledge-aided Assessment and Structured Application (KASA) system and the Office of Generic Drugs Label Review Tool (LRT). For KASA, fiscal year 2022 enhancements focus on expanding functionality through the addition of the Drug Substance module, ATL summary capabilities, ANDA Liquid Dosage assessments, and Integrated Assessment workflows. The LRT serves as a unified platform that consolidates diverse data sources into a single interface, enabling reviewers to perform labeling assessments using the standard OGD review template. The work also involves maintaining the newly deployed Appian-based infrastructure and adding new features such as enhanced workflows, system integrations, and improved reporting tools to increase efficiency and accuracy in regulatory reviews. The contract structure includes base performance years with optional recurring periods to ensure sustained support and evolution of these systems.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
